DCAL is undervalued compared to peers (LAURUS LABS, NEULAND LABS etc) in Specialty Chemical space. While it is a turnaround story in the making at a fundamental level, it is interesting to note how it is following the Fib retracement patterns.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
